Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response

American Journal of Pathology

Volumn 168, Issue 3, 2006, Pages 812-821

  Matsushita, Takashi ^a   Fujimoto, Manabu ^a   Hasegawa, Minoru ^a   Komura, Kazuhiro ^a   Takehara, Kazuhiko ^a   Tedder, Thomas F ^b   Sato, Shinichi ^a,c  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM; SERUM; SIGNAL TRANSDUCTION; TH2 CELL;

EID: 33644657466     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050923     Document Type: Article

References (47)

1. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM: B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950
2. Mauri C, Gray D, Mushtaq N, Londei M: Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003, 197:489-501
3. Saito E, Fujimoto M, Hasegawa M, Komura K, Hamaguchi Y, Kaburagi Y, Nagaoka T, Takehara K, Tedder TF, Sato S: CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 2002, 109:1453-1462
4. Weinstein E, Peeva E, Putterman C, Diamond B: B-cell biology. Rheum Dis Clin North Am 2004, 30:159-174
5. Chan OT, Madaio MP, Shlomchik MJ: B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 1999, 163:3592-3596
6. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz A, Carroll MC, Brenner M, Weissleder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D: Arthritis critically dependent on innate immune system players. Immunity 2002, 16:157-168
7. Lipsky PE: Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001, 2:764-766
8. Martin F, Chan AC: Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 2004, 20:517-527
9. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004, 350:2572-2581
10. Shaw T, Quan J, Totoritis MC: B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience. Ann Rheum Dis 2003, 62(Suppl 2):ii55-ii59
11. Williams KC, Ulvestad E, Hickey WF: Immunology of multiple sclerosis. Clin Neurosci 1994, 2:229-245
12. Kuchroo VK, Martin CA, Greer JM, Ju ST, Sobel RA, Dorf ME: Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993, 151:4371-4382
13. Khoury SJ, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992, 176:1355-1364
14. Kennedy MK, Torrance DS, Picha KS, Mohler KM: Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992, 149:2496-2505
15. - T lymphocytes. J Immunol 1981, 127:1420-1423
16. Wolf SD, Dittel BN, Hardardottir F, Janeway Jr CA: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996, 184:2271-2278
17. Cross AH, Trotter JL, Lyons J: B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 2001, 112:1-14
18. Du C, Sriram S: Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system. J Immunol 2002, 168:3105-3112
19. Linington C, Bradl M, Lassmann H, Brunner C, Vass K: Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988, 130:443-454
20. Lyons JA, San M, Happ MP, Cross AH: B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 1999, 29:3432-3439
21. Tsubata T: Co-receptors on B lymphocytes. Curr Opin Immunol 1999, 11:249-255
22. Fujimoto M, Fujimoto Y, Poe JC, Jansen PJ, Lowell CA, DeFranco AL, Tedder TF: CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 2000, 13:47-57
23. Tedder TF, Poe JC, Fujimoto M, Haas KM, Sato S: The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun 2005, 8:55-90
24. Fujimoto M, Poe JC, Hasegawa M, Tedder TF: CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification. Immunol Res 2000, 22:281-298
25. Rickert RC, Rajewsky K, Roes J: Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995, 376:352-355
26. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF: Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995, 3:39-50
27. Asano N, Fujimoto M, Yazawa N, Shirasawa S, Hasegawa M, Okochi H, Tamaki K, Tedder TF, Sato S: B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol 2004, 165:641-650
28. Sato S, Steeber DA, Tedder TF: The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA 1995, 92:11558-11562
29. Bloch G, Toma DP, Robinson GE: Behavioral rhythmicity, age, division of labor and period expression in the honey bee brain. J Biol Rhythms 2001, 16:444-456
30. Zeine R, Owens T: Direct demonstration of the infiltration of murine central nervous system by Pgp-1/CD44high CD45RB(low) CD4+ T cells that induce experimental allergic encephalomyelitis. J Neuroimmunol 1992, 40:57-69
31. Hjelmstrom P, Juedes AE, Fjell J, Ruddle NH: B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol 1998, 161:4480-4483
32. Su L, Rickert RC, David M: Rapid STAT phosphorylation via the B cell receptor. Modulatory role of CD19. J Biol Chem 1999, 274:31770-31774
33. Pang Y, Norihisa Y, Benjamin D, Kantor RR, Young HA: Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood 1992, 80:724-732
34. Dayton MA, Knobloch TJ, Benjamin D: Human B cell lines express the interferon gamma gene. Cytokine 1992, 4:454-460
35. Jelinek DF, Braaten JK: Role of IL-12 in human B lymphocyte proliferation and differentiation. J Immunol 1995, 154:1606-1613
36. Metzger DW, Vogel LA, Van Cleave VH, Lester TL, Buchanan JM: The effects of IL12 on B-cell subset function. Res Immunol 1995, 146:499-505
37. Vogel LA, Lester TL, Van Cleave VH, Metzger DW: Inhibition of murine B1 lymphocytes by interleukin-12. Eur J Immunol 1996, 26:219-223
38. Li L, Young D, Wolf SF, Choi YS: Interleukin-12 stimulates B cell growth by inducing IFN-gamma. Cell Immunol 1996, 168:133-140
39. Trinchieri G: Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998, 70:83-243
40. Airoldi I, Gri G, Marshall JD, Corcione A, Facchetti P, Guglielmino R, Trinchieri G, Pistoia V: Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. J Immunol 2000, 165:6880-6888
41. Zhang YP, Tzartos SJ, Wekerle H: B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor. Eur J Immunol 1988, 18:211-218
42. Stockinger B, Zal T, Zal A, Gray D: B cells solicit their own help from T cells. J Exp Med 1996, 183:891-899
43. Macaulay AE, DeKruyff RH, Goodnow CC, Umetsu DT: Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4. J Immunol 1997, 158:4171-4179
44. Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, Wekerle H, Raine CS: Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001, 166:7579-7587
45. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schroder R, Deckert M, Schmidt S, Ravid R, Rajewsky K: Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000, 192:393-404
46. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M: A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999, 46:878-886
47. Kieseier BC, Hartung HP: Current disease-modifying therapies in multiple sclerosis. Semin Neurol 2003, 23:133-146